Enanta Pharmaceuticals Inc (ENTA)
13.23
-0.77
(-5.50%)
USD |
NASDAQ |
Apr 18, 16:00
13.24
+0.01
(+0.08%)
Pre-Market: 20:00
Enanta Pharmaceuticals Total Assets (Quarterly): 428.50M for Dec. 31, 2023
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 428.50M |
| September 30, 2023 | 462.28M |
| June 30, 2023 | 495.17M |
| March 31, 2023 | 326.44M |
| December 31, 2022 | 347.53M |
| September 30, 2022 | 375.41M |
| June 30, 2022 | 385.21M |
| March 31, 2022 | 406.82M |
| December 31, 2021 | 440.59M |
| September 30, 2021 | 438.79M |
| June 30, 2021 | 450.44M |
| March 31, 2021 | 467.77M |
| December 31, 2020 | 481.01M |
| September 30, 2020 | 486.13M |
| June 30, 2020 | 511.70M |
| March 31, 2020 | 513.50M |
| December 31, 2019 | 510.97M |
| September 30, 2019 | 489.83M |
| June 30, 2019 | 473.48M |
| March 31, 2019 | 461.58M |
| December 31, 2018 | 454.22M |
| September 30, 2018 | 414.23M |
| June 30, 2018 | 379.08M |
| March 31, 2018 | 354.65M |
| Date | Value |
|---|---|
| December 31, 2017 | 340.72M |
| September 30, 2017 | 326.64M |
| June 30, 2017 | 275.84M |
| March 31, 2017 | 278.96M |
| December 31, 2016 | 278.38M |
| September 30, 2016 | 281.28M |
| June 30, 2016 | 281.93M |
| March 31, 2016 | 281.60M |
| December 31, 2015 | 278.38M |
| September 30, 2015 | 246.01M |
| June 30, 2015 | 237.77M |
| March 31, 2015 | 245.88M |
| December 31, 2014 | 215.43M |
| September 30, 2014 | 155.42M |
| June 30, 2014 | 159.51M |
| March 31, 2014 | 108.35M |
| December 31, 2013 | 110.16M |
| September 30, 2013 | 116.97M |
| June 30, 2013 | 119.67M |
| March 31, 2013 | 125.63M |
| December 31, 2012 | 72.48M |
| September 30, 2012 | 52.16M |
| June 30, 2012 | 54.33M |
| September 30, 2011 | 26.10M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
326.44M
Minimum
Mar 2023
513.50M
Maximum
Mar 2020
446.93M
Average
462.28M
Median
Sep 2023
Total Assets (Quarterly) Benchmarks
| Madrigal Pharmaceuticals Inc | 640.55M |
| Galectin Therapeutics Inc | 28.20M |
| Viking Therapeutics Inc | 368.49M |
| Akero Therapeutics Inc | 580.27M |
| 89bio Inc | 596.27M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 236.62M |
| Shareholders Equity (Quarterly) | 191.88M |
| Current Ratio | 6.254 |